Stephen Lawn
#134,263
Most Influential Person Now
Academic who researched tuberculosis among AIDS sufferers
Stephen Lawn's AcademicInfluence.com Rankings
Stephen Lawnmedical Degrees
Medical
#2433
World Rank
#2858
Historical Rank
Epidemiology
#473
World Rank
#495
Historical Rank
Stephen Lawnphilosophy Degrees
Philosophy
#7497
World Rank
#10718
Historical Rank
Logic
#4542
World Rank
#5851
Historical Rank
Download Badge
Medical Philosophy
Stephen Lawn's Degrees
- Masters Medicine University of Cape Town
- PhD Epidemiology University of Cape Town
Why Is Stephen Lawn Influential?
(Suggest an Edit or Addition)According to Wikipedia, Stephen David Lawn was a Professor of Infectious diseases and Tropical medicine known for research on tuberculosis and HIV/AIDS. Personal life Lawn was married to Professor Joy Lawn. They have a son, Tim, and a daughter, Joanna.
Stephen Lawn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa (2008) (714)
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. (2008) (660)
- Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. (2005) (584)
- HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response (2009) (561)
- Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. (2011) (436)
- Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. (2013) (418)
- Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design (2005) (410)
- Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies (2011) (391)
- Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control (2006) (388)
- Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort (2005) (382)
- Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis (2012) (364)
- Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa (2007) (352)
- Extensively drug resistant tuberculosis (2006) (351)
- Soluble Forms of Toll-Like Receptor (TLR)2 Capable of Modulating TLR2 Signaling Are Present in Human Plasma and Breast Milk (2003) (349)
- Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa (2009) (319)
- Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection (2001) (309)
- Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review (2012) (308)
- Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. (2009) (303)
- Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study (2011) (301)
- Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study (2012) (300)
- Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis (2015) (282)
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. (2010) (272)
- The HIV-associated tuberculosis epidemic—when will we act? (2010) (269)
- Drug-resistant tuberculosis: time for visionary political leadership. (2013) (263)
- Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. (2007) (262)
- Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. (2006) (254)
- Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. (2006) (252)
- Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. (2013) (236)
- Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review (2012) (229)
- Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. (2008) (212)
- Pulmonary tuberculosis: diagnostic delay in Ghanaian adults. (1998) (206)
- Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community (2012) (204)
- Epidemiology of HIV-associated tuberculosis (2009) (202)
- Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease (2009) (197)
- Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. (2012) (197)
- Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. (2006) (189)
- Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review (2014) (181)
- Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. (2010) (179)
- Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. (2012) (172)
- How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control (2005) (171)
- Conservation of First-Line Antiretroviral Treatment Regimen where Therapeutic Options are Limited (2007) (168)
- Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. (2002) (165)
- Linkage to HIV Care and Antiretroviral Therapy in Cape Town, South Africa (2010) (160)
- Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. (2010) (151)
- AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. (2004) (151)
- Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa (2009) (140)
- Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis (2010) (139)
- Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults (2016) (138)
- Changes in Programmatic Outcomes During 7 Years of Scale-up at a Community-Based Antiretroviral Treatment Service in South Africa (2011) (138)
- CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa (2006) (137)
- Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial (2018) (136)
- Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa (2010) (135)
- Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. (2005) (133)
- Interactions between HIV infection and leprosy: a paradox. (2006) (128)
- Tuberculosis in Antiretroviral Treatment Services in Resource-Limited Settings: Addressing the Challenges of Screening and Diagnosis (2011) (127)
- Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study (2006) (125)
- Diagnosis of extrapulmonary tuberculosis using the Xpert® MTB/RIF assay (2012) (124)
- Accelerated biological ageing in HIV-infected individuals in South Africa: a case–control study (2013) (121)
- Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings (2009) (121)
- Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa (2013) (119)
- Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa (2012) (118)
- Treatment Interruption in a Primary Care Antiretroviral Therapy Program in South Africa: Cohort Analysis of Trends and Risk Factors (2010) (116)
- Tuberculosis (2011) (115)
- The Phenotype of the Cryptococcus-Specific CD4+ Memory T-Cell Response Is Associated With Disease Severity and Outcome in HIV-Associated Cryptococcal Meningitis (2013) (115)
- Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? (2011) (114)
- Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. (2003) (113)
- Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy (2010) (112)
- Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings (2010) (112)
- Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-Status (2011) (110)
- Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort (2017) (105)
- Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. (2010) (105)
- An Incentivized HIV Counseling and Testing Program Targeting Hard-to-Reach Unemployed Men in Cape Town, South Africa (2012) (104)
- New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. (2004) (103)
- The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals (2000) (97)
- Frailty in HIV-Infected Adults in South Africa (2013) (96)
- Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. (2009) (94)
- Changing Concepts of “Latent Tuberculosis Infection” in Patients Living with HIV Infection (2010) (92)
- Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications (2016) (90)
- Tuberculosis control has failed in South Africa--time to reappraise strategy. (2011) (88)
- The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis (2012) (85)
- Characteristics and Early Outcomes of Patients With Xpert MTB/RIF-Negative Pulmonary Tuberculosis Diagnosed During Screening Before Antiretroviral Therapy (2012) (84)
- Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting (2008) (84)
- Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy (2011) (84)
- Cellular Compartments of Human Immunodeficiency Virus Type 1 Replication In Vivo: Determination by Presence of Virion-Associated Host Proteins and Impact of Opportunistic Infection (2000) (84)
- Tuberculosis transmission to young children in a South African community: modeling household and community infection risks. (2010) (82)
- The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents (2006) (82)
- Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. (2009) (79)
- Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans. (1999) (76)
- Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa (2007) (76)
- Support and performance improvement for primary health care workers in low- and middle-income countries: a scoping review of intervention design and methods (2016) (75)
- Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies (2013) (74)
- Immune reconstitution disease associated with parasitic infections following antiretroviral treatment (2006) (73)
- Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study (2012) (72)
- Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria (2012) (72)
- Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. (2011) (70)
- Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa (2015) (69)
- Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis (2012) (68)
- HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up (2015) (67)
- Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection. (2001) (67)
- Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis (2016) (66)
- Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. (2000) (66)
- Human cystic echinococcosis: evaluation of post-treatment serologic follow-up by IgG subclass antibody detection. (2004) (63)
- Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa (2013) (63)
- Tuberculosis in a South African prison - a transmission modelling analysis. (2011) (62)
- Dengue hemorrhagic fever with fulminant hepatic failure in an immigrant returning to Bangladesh. (2003) (60)
- Disseminated tuberculosis among hospitalised HIV patients in South Africa: a common condition that can be rapidly diagnosed using urine-based assays (2017) (60)
- HIV and tuberculosis – science and implementation to turn the tide and reduce deaths (2012) (59)
- Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration. (2011) (59)
- Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis. (2013) (58)
- High Diagnostic Yield of Tuberculosis From Screening Urine Samples From HIV-Infected Patients With Advanced Immunodeficiency Using The Xpert MTB/RIF Assay (2012) (58)
- Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travellers. (2006) (58)
- High Prevalence of Self-Reported Undiagnosed HIV despite High Coverage of HIV Testing: A Cross-Sectional Population Based Sero-Survey in South Africa (2011) (57)
- Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections (2011) (56)
- Cryptococcal Antigen Screening and Preemptive Therapy in Patients Initiating Antiretroviral Therapy in Resource-Limited Settings (2012) (55)
- Indoor Social Networks in a South African Township: Potential Contribution of Location to Tuberculosis Transmission (2012) (55)
- HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays (2013) (55)
- Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa (2012) (55)
- Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials? (2016) (54)
- Immune activation and induction of HIV-1 replication within CD14 macrophages during acute Plasmodium falciparum malaria coinfection (2002) (54)
- Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review (2013) (54)
- Elevated serum concentrations of soluble CD14 in HIV− and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti‐tuberculosis treatment (2000) (53)
- Pyomyositis and cutaneous abscesses due to Mycobacterium avium: an immune reconstitution manifestation in a patient with AIDS. (2004) (52)
- The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study (2015) (52)
- Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township (2011) (51)
- Resolution of the acute-phase response in West African patients receiving treatment for pulmonary tuberculosis. (2000) (51)
- Predictive Value of Anemia for Tuberculosis in HIV-Infected Patients in Sub-Saharan Africa: An Indication for Routine Microbiological Investigation Using New Rapid Assays (2014) (50)
- Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries. (2005) (50)
- Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America (2004) (49)
- Community Viral Load and CD4 Count Distribution Among People Living With HIV in a South African Township: Implications for Treatment as Prevention (2013) (48)
- Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa. (2010) (45)
- Pulmonary tuberculosis: radiological features in west Africans coinfected with HIV. (1999) (45)
- Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa (2014) (45)
- Relationship Between Blood Concentrations of Hepcidin and Anemia Severity, Mycobacterial Burden, and Mortality Among Patients With HIV-Associated Tuberculosis (2015) (44)
- Integrated care as a means to improve primary care delivery for adults and adolescents in the developing world: a critical analysis of Integrated Management of Adolescent and Adult Illness (IMAI) (2014) (44)
- Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa. (2013) (44)
- Immune reconstitution disease associated with parasitic infections following initiation of antiretroviral therapy (2007) (44)
- Case report: Schistosoma mansoni infection: failure of standard treatment with praziquantel in a returned traveller. (2003) (44)
- Incorporation of HLA-DR into the Envelope of Human Immunodeficiency Virus Type 1 In Vivo: Correlation with Stage of Disease and Presence of Opportunistic Infection (2000) (43)
- Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. (2011) (43)
- Anaemia in patients with HIV-associated TB: relative contributions of anaemia of chronic disease and iron deficiency (2016) (40)
- Spoligotyping in molecular epidemiology of tuberculosis in Ghana. (1999) (40)
- Rates of Switching Antiretroviral Drugs in a Primary Care Service in South Africa before and after Introduction of Tenofovir (2013) (39)
- Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: A cross-sectional study (2009) (39)
- Case reports: pernicious complications of benign tertian malaria. (2003) (38)
- Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact. (2012) (37)
- Systematic Review of TST Responses in People Living with HIV in Under-Resourced Settings: Implications for Isoniazid Preventive Therapy (2012) (37)
- The eye as a model of ageing in translational research – Molecular, epigenetic and clinical aspects (2013) (37)
- Hypercalcemia: a manifestation of immune reconstitution complicating tuberculosis in an HIV-infected person. (2004) (37)
- Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action. (2010) (37)
- Prognostic Value of a Quantitative Analysis of Lipoarabinomannan in Urine from Patients with HIV-Associated Tuberculosis (2014) (35)
- Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa (2007) (35)
- Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact [Correspondence]. (2012) (33)
- Pulmonary tuberculosis in adults: factors associated with mortality at a Ghanaian teaching hospital. (1999) (33)
- Serum C-reactive protein and detection of tuberculosis in persons co-infected with the human immunodeficiency virus. (2001) (32)
- Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individuals. (2011) (32)
- Tuberculosis in Ghana: social stigma and compliance with treatment. (2000) (32)
- Provider-initiated HIV testing increases access of patients with HIV-associated tuberculosis to antiretroviral treatment. (2011) (32)
- Immune reconstitution disease associated with mycobacterial infections (2008) (31)
- Time to Initiation of Antiretroviral Therapy Among Patients With HIV-Associated Tuberculosis in Cape Town, South Africa (2011) (31)
- Bioaerosol production by patients with tuberculosis during normal tidal breathing: implications for transmission risk (2016) (31)
- Delays in the diagnosis of tuberculosis: a great new cost. (1997) (31)
- Underestimation of the True Specificity of the Urine Lipoarabinomannan Point-of-Care Diagnostic Assay for HIV-Associated Tuberculosis. (2015) (30)
- Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world? (2005) (30)
- Predicting the Long-Term Impact of Antiretroviral Therapy Scale-Up on Population Incidence of Tuberculosis (2013) (30)
- Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. (2019) (28)
- When should antiretroviral treatment be started in patients with HIV-associated tuberculosis in South Africa? (2007) (28)
- Blood Neutrophil Counts in HIV-Infected Patients with Pulmonary Tuberculosis: Association with Sputum Mycobacterial Load (2013) (28)
- Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease? (2010) (27)
- Identification of losses to follow-up in a community-based antiretroviral therapy clinic in South Africa using a computerized pharmacy tracking system (2010) (27)
- Acute bilateral parotitis caused by Mycobacterium scrofulaceum: immune reconstitution disease in a patient with AIDS (2005) (27)
- Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa (2011) (26)
- How can earlier entry of patients into antiretroviral programs in low-income countries be promoted? (2006) (26)
- Hepatic involvement with tuberculosis-associated immune reconstitution disease. (2007) (25)
- Retinal Arterioles Narrow with Increasing Duration of Anti-Retroviral Therapy in HIV Infection: A Novel Estimator of Vascular Risk in HIV? (2012) (25)
- Retinal Nerve Fibre Layer Thickness and Contrast Sensitivity in HIV-Infected Individuals in South Africa: A Case-Control Study (2013) (25)
- The African challenge (2002) (25)
- Increasing Transfers-Out from an Antiretroviral Treatment Service in South Africa: Patient Characteristics and Rates of Virological Non-Suppression (2013) (24)
- Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa? (2011) (23)
- Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial (2016) (23)
- Corneal Endothelial Cells Provide Evidence of Accelerated Cellular Senescence Associated with HIV Infection: A Case-Control Study (2013) (23)
- Postmalaria neurological syndrome: two cases from the Gambia. (2003) (23)
- Leprosy after starting antiretroviral treatment (2007) (23)
- Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study (2019) (22)
- Antiretroviral Treatment as Prevention: Impact of the ‘Test and Treat’ Strategy on the Tuberculosis Epidemic (2011) (22)
- Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource-limited settings (2007) (22)
- Increased Ocular Lens Density in HIV-Infected Individuals With Low Nadir CD4 Counts in South Africa: Evidence of Accelerated Aging (2013) (22)
- Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. (2015) (22)
- Monitoring of antiretroviral therapy in low-resource settings (2008) (22)
- Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation. (2015) (22)
- Tuberculosis control in South Africa--will HAART help? (2006) (21)
- PEPFAR Support for the Scaling Up of Collaborative TB/HIV Activities (2012) (20)
- Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults. (2020) (20)
- Pulmonary tuberculosis in Kumasi, Ghana: presentation, drug resistance, molecular epidemiology and outcome of treatment. (2001) (19)
- Dynamic variation in the cellular origin of HIV type 1 during treatment of tuberculosis in dually infected subjects. (2007) (19)
- Optimum time to initiate antiretroviral therapy in patients with HIV-associated tuberculosis: there may be more than one right answer. (2007) (19)
- Tuberculosis research update (2010) (19)
- Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality? (2010) (18)
- Promoting retention in care: an effective model in an antiretroviral treatment service in South Africa. (2007) (18)
- ART and prevention of HIV-associated tuberculosis. (2015) (17)
- Assessment of candidate ocular biomarkers of ageing in a South African adult population: Relationship with chronological age and systemic biomarkers☆ (2013) (17)
- Poor Prognosis of HIV-Associated Tuberculous Meningitis Regardless of the Timing of Antiretroviral Therapy (2011) (17)
- Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy. (2012) (16)
- HIV/AIDS: a new South Africa takes responsibility. (2009) (16)
- Risk factors for tuberculosis among HIV-infected patients receiving antiretroviral treatment. (2005) (16)
- Chapter 10 – Co-pathogenesis of tuberculosis and HIV (2009) (15)
- Should the CD4 threshold for starting ART be raised? (2009) (15)
- New World cutaneous leishmaniasis in returned travellers: treatment failures using intravenous sodium stibogluconate. (2003) (14)
- Anemia, Blood Transfusion Requirements and Mortality Risk in Human Immunodeficiency Virus-Infected Adults Requiring Acute Medical Admission to Hospital in South Africa (2015) (14)
- Point-of-care urine antigen screening tests for tuberculosis and cryptococcosis: potential for mortality reduction in antiretroviral treatment programs in Africa. (2012) (14)
- A breakthrough urine-based diagnostic test for HIV-associated tuberculosis (2016) (14)
- Multiple dermatofibroma‐like lesions in a human immunodeficiency virus‐positive patient coinfected with visceral leishmaniasis (2003) (14)
- Advances in Diagnostic Assays for Tuberculosis. (2015) (14)
- The irreversible cost of delayed diagnosis of tuberculosis in HIV co-infected persons in sub-Saharan Africa. (2001) (13)
- Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy [Short communication]. (2012) (13)
- Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis. (2013) (13)
- Serum procalcitonin concentrations in patients with pulmonary tuberculosis. (1998) (13)
- Underestimation of the incremental diagnostic yield of HIV-associated tuberculosis in studies of the Determine TB-LAM Ag urine assay. (2014) (13)
- Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services. (2012) (13)
- Reducing tuberculosis-associated early mortality in antiretroviral treatment programmes in sub-Saharan Africa. (2011) (13)
- Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis (2012) (12)
- Ocular parameters of biological ageing in HIV-infected individuals in South Africa: Relationship with chronological age and systemic biomarkers of ageing (2013) (12)
- CD 4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa (2015) (12)
- Case reports: acute hookworm infection: an unusual cause of profuse watery diarrhoea in returned travellers. (2003) (12)
- Evaluating a model for monitoring the virological efficacy of antiretroviral treatment in resource-limited settings. (2006) (11)
- Rapid diagnosis of TB in HIV-positive in-patients with M. tuberculosis bacteraemia in sub-Saharan Africa. (2015) (11)
- Tuberculosis 2013 : 3 Tuberculosis comorbidity with communicable and non-communicable diseases : integrating health services and control eff orts (2013) (10)
- What is the role for Xpert® MTB/RIF in high-resource settings? Experience from a central London hospital. (2014) (10)
- Temporal Association Between Incident Tuberculosis and Poor Virological Outcomes in a South African Antiretroviral Treatment Service (2013) (10)
- Urine lateral flow lipoarabinomannan assay for diagnosing active tuberculosis in adults living with HIV (2014) (10)
- Tuberculosis transmission from patients with smear-negative pulmonary tuberculosis in sub-Saharan Africa. (2009) (9)
- Editorial Commentary: Dead or Alive: Can Viability Staining Predict Response to Tuberculosis Treatment? (2014) (9)
- Accuracy of the Xpert MTB/RIF assay for diagnosis of extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review (2014) (9)
- Strengthening of primary-care delivery in the developing world: IMAI and the need for integrated models of care. (2013) (9)
- Acute respiratory failure due to Mycobacterium kansasii infection: immune reconstitution disease in a patient with AIDS. (2005) (9)
- Immune reconstitution inflammatory syndrome. (2010) (9)
- Assessing the impact of prevalent tuberculosis on mortality among antiretroviral treatment initiators: accurate tuberculosis diagnosis is essential. (2012) (9)
- The epidemic of HIV-associated tuberculosis in sub-Saharan Africa: does this also impact non-HIV-infected individuals? (2006) (8)
- Diagnosis of pulmonary tuberculosis (2013) (8)
- A black necrotic ulcer (2003) (8)
- Tuberculosis and HIV co-infection (2005) (8)
- Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes. (2011) (8)
- Tuberculosis screening in patients starting antiretroviral therapy in sub-Saharan Africa: stretching diagnostics to the limits. (2011) (8)
- Concurrent drug therapy for tuberculosis and HIV infection in resource-limited settings: present status and future prospects (2007) (7)
- Reducing the burden of tuberculosis presenting during the initial months of antiretroviral therapy in resource-limited settings. (2010) (7)
- The Hannan Crusaid Treatment Centre – early beginnings and lessons learnt (2014) (7)
- HIV infection in tuberculosis patients in Kumasi, Ghana (1997) (7)
- Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy? (2012) (7)
- Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis? (2011) (7)
- The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic review (2013) (7)
- Lack of induction of interleukin-2-receptor-alpha in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis. (2001) (7)
- HIV testing in people with presumptive tuberculosis: time for implementation. (2013) (7)
- National adult antiretroviral therapy guidelines in South Africa: concordance with 2003 WHO guidelines? (2007) (6)
- Impact of antituberculosis treatment on virological response to highly active antiretroviral therapy: implications for resource-limited settings? (2006) (6)
- Screening for active tuberculosis among patients accessing antiretroviral therapy in sub-Saharan Africa. (2009) (6)
- Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis (2019) (5)
- Life-threatening cutaneous reactions to thiacetazone-containing antituberculosis treatment in Kumasi, Ghana. (1999) (5)
- CD4 cell count distributions and HIV-associated mortality in Africa. (2007) (5)
- Antiretroviral therapy for control of the HIV-associated MDR and XDR tuberculosis epidemic in South Africa. (2010) (5)
- Chickenpox oesophagitis and haematemesis in an immunocompetent adult. (2002) (4)
- Tuberculosis in hospitalised patients with HIV: clinical characteristics, mortality, and implications from the STAMP trial. (2019) (4)
- Iron replacement therapy and anemia associated with chronic infectious diseases in sub-Saharan Africa. (2015) (4)
- HIV Infection in Tuberculosis Patients in Kumasi. (1997) (4)
- Primate model to study reactivation of TB associated with retroviral infection (2010) (4)
- Serological Diagnostic Assays for HIV-Associated Tuberculosis in Sub-Saharan Africa? (2014) (4)
- Tuberculosis in Hospitalized Patients With Human Immunodeficiency Virus: Clinical Characteristics, Mortality, and Implications From the Rapid Urine-based Screening for Tuberculosis to Reduce AIDS Related Mortality in Hospitalized Patients in Africa (2019) (3)
- Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa (2020) (3)
- Antiretroviral Treatment Cohort Analysis Using Time-Updated CD4 Counts: Assessment of Bias with Different Analytic Methods (2011) (3)
- Utility of CD 4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting (2008) (3)
- Are the effects of isoniazid preventive therapy and highly active antiretroviral therapy additive in preventing HIV-associated tuberculosis? (2009) (3)
- Reducing Mortality Associated with Opportunistic Infections among Patients with Advanced HIV Infection in Sub-Saharan Africa: Reply to DiNubile (2009) (3)
- Schistosoma mansoni infection: Failure ofstandard treatment with praziquantel in a returned traveller: A reply. (2003) (3)
- Timing of antiretroviral therapy for HIV-1-associated tuberculosis. (2012) (2)
- ‘Getting to Zero’: are there grounds for optimism in the global fight against HIV? (2012) (2)
- Type A intracytoplasmic inclusions in human cowpox infection. (2004) (2)
- Urine antigen test for diagnosis of HIV-associated tuberculosis – Authors' reply (2012) (2)
- Advances in the Diagnosis of HIV-Associated Tuberculosis (2015) (2)
- Video Q&A: Rapid urine LAM test for HIV-associated TB - potential to reduce deaths? An interview with Stephen Lawn (2013) (2)
- Preventing HIV-associated tuberculosis with antiretroviral therapy: shut the stable door early! (2015) (2)
- Schistosomiasis and immune reconstitution disease. (2007) (2)
- TB and HIV: how can we reduce mortality? (2012) (2)
- Serum C-reactive protein measurement for ruling out HIV-associated tuberculosis. (2013) (2)
- Mycobacterium-associated immune reconstitution disease: macrophages running wild? Author's reply (2006) (2)
- BMC medicine editorial board members on open access publishing (2014) (1)
- Correction: Predicting the Long-Term Impact of Antiretroviral Therapy Scale-Up on Population Incidence of Tuberculosis (2013) (1)
- Africa--not lost but still sick. Implementing interventions to prevent HIV-associated tuberculosis. (2014) (1)
- Characteristics of Xpert MTB/RIF-Negative Patients With Pulmonary Tuberculosis Reply (2012) (1)
- In reply to 'Empirical tuberculosis treatment or improved diagnostics?' [Correspondence]. (2012) (1)
- Bio-aerosol production by patients with tuberculosis during normal tidal breathing: implications for transmission risk: a cohort study (2015) (1)
- 96 – Tuberculosis in HIV (2017) (1)
- Anti-leishmanial drugs for treating visceral leishmaniasis. (2004) (1)
- Cytomegalovirus retinitis associated with HIV in resource-constrained settings: systematic screening and case detection. (2012) (1)
- Reply to Theron et al (2012) (1)
- Correction: Systematic Review of TST Responses in People Living with HIV in Under-Resourced Settings: Implications for Isoniazid Preventive Therapy (2013) (1)
- In reply to 'C-reactive protein and tuberculosis screening: a new trick for an old dog?'. (2013) (1)
- Are the effects of isoniazid preventive therapy and HAART additive in preventing of HIV-associated tuberculosis? (2013) (1)
- Reply to Ouattara et al.: past history of tuberculosis is not a risk factor for incident tuberculosis during antiretroviral treatment in South Africa. (2007) (1)
- Therapy for Severe Histoplasmosis: What's Best? (2004) (1)
- Rapid Urine-Based Screening for Tuberculosis to Reduce AIDS-Related Mortality in Hospitalized Patients in Africa (STAMP) Trial Protocol (2018) (1)
- Concurrent treatment of tuberculosis and HIV infection: current status and future prospects. (2007) (0)
- The immune reconstitution inflammatory syndrome: a systematic review (2014) (0)
- Confronting tuberculosis in the era of HIV (2012) (0)
- Tuberculosis and HIV Coinfection (Review) (2005) (0)
- Reply to Boyles: testing for lipoarabinomannan in patients with advanced immunodeficiency - much to gain and little to lose. (2012) (0)
- Chapter 93 – Tuberculosis in HIV (2010) (0)
- THE 3 I ’ s SATELLITE SYMPOSIUM : REDUCING THE RISK OF TUBERCULOSIS IN HIV-INFECTED INDIVIDUALS (2009) (0)
- Sensitivity and Specificity of Clinical Parameters and CD4 Count in Predicting HIV-Associated Eye Disease (2010) (0)
- Disseminated tuberculosis among hospitalised HIV patients in South Africa: a common condition that can be rapidly diagnosed using urine-based assays (2017) (0)
- Clinical examination versus Chlamydia trachomatis assays to guide antibiotic use in trachoma control programmes (2006) (0)
- Reflection and Reaction (2006) (0)
- Erratum to: Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial (2016) (0)
- Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy? [Editorial]. (2012) (0)
- Use of Veterinary Vaccines Associated with Illness in a Man (2004) (0)
- Early Mortality Among Patients with HIV-Associated Tuberculosis in Africa : Implications for the Time to Initiation of Antiretroviral Treatment (2007) (0)
- Enhancing the impact of antiretroviral scale-up on the HIV-associated tuberculosis epidemic in Malawi. (2014) (0)
- Effect of parenchymal abnormalities on bioaerosol production by patients with TB. (2022) (0)
- Past history of tuberculosis is not a risk factor for incident tuberculosis during antiretroviral treatment in South Africa [letter] [reply] (2007) (0)
- ' s report Title : LAM-ELISA shows a low sensitivity for the diagnosis of pulmonary tuberculosis in urine Version : 1 Date : 22 May 2009 (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Bronchiectasis: Frequent Misdiagnosis in Sub-Saharan Africa (1999) (0)
- Principles of Medicine in Africa: Tuberculosis (2013) (0)
- Further consequences of thioacetazone-induced cutaneous reactions. (2000) (0)
- Erratum: Xpert® MTB/RIF assay: Development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance (Future Microbiology (2011) 6:9 (1067-1082)) (2012) (0)
- Reviewer ' s report Title : Basis for treatment of tuberculosis among HIV-infected patients in Tanzania : the role of chest x-ray and sputum culture (0)
- The applicability of empiric antituberculosis treatment (1996) (0)
- Optimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis: A Reply (2009) (0)
- Acute dystonic reaction after Heaf test. (1995) (0)
- Present in Human Plasma and Breast Milk Capable of Modulating TLR2 Signaling Are Soluble Forms of Toll-Like Receptor (TLR)2 (2003) (0)
- The application of empiric antituberculosis treatment. (1996) (0)
This paper list is powered by the following services:
Other Resources About Stephen Lawn
What Schools Are Affiliated With Stephen Lawn?
Stephen Lawn is affiliated with the following schools:
